Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06545643 · ClinicalTrials.gov registry record · NA
Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs
A NA study, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT06545643 is a NA study that is actively recruiting participants, run by Duke University. The registered enrollment target is 35 participants.
The verdict
NCT06545643, a NA study, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
Epilepsy, a prevalent neurological disorder, affects 40% of patients with uncontrolled seizures despite medications. Sleep disturbance exacerbates epilepsy, and vice versa, but existing literature suffers from limitations. Studies conducted in hospital settings provide only brief observation periods and fail to capture the natural sleep environment. Wearable technology offers a promising solution, providing a nuanced understanding of the relationship between seizures and sleep. The Dreem headband, an EEG-based wearable, is well-suited for such studies, offering ease of use and validated accuracy. This technology enables extended observation periods under stable medication conditions, essential for assessing the complex interplay between sleep and epilepsy. By elucidating the impact of sleep on seizures, the researchers seek to identify patient populations where sleep significantly influences seizure susceptibility, ultimately informing personalized epilepsy treatments.
Interventions
- DEVICE Dreem headband
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2025-05-01 |
| Est. Completion | 2028-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06545643
The ClinicalTrials.gov registry entry for NCT06545643 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dreem headband is the first listed.
NCT06545643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06545643 about?
NCT06545643 is a clinical study titled "Sleep-Sensitive Seizure Risk Assessment With Wearable EEGs". Epilepsy, a prevalent neurological disorder, affects 40% of patients with uncontrolled seizures despite medications. Sleep disturbance exacerbates epilepsy, and vice versa, but existing literature suffers from limitations. Studies conducted in hospital settings provide only brief observation periods...
What is the current status of trial NCT06545643?
This trial is currently recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2025-05-01. Estimated completion is 2028-06-01.
What interventions are being tested in trial NCT06545643?
The interventions under investigation include: Dreem headband (DEVICE).
Who is sponsoring clinical trial NCT06545643?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.